305 related articles for article (PubMed ID: 30398465)
1. Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema.
Haslund D; Ryø LB; Seidelin Majidi S; Rose I; Skipper KA; Fryland T; Bohn AB; Koch C; Thomsen MK; Palarasah Y; Corydon TJ; Bygum A; Nejsum LN; Mikkelsen JG
J Clin Invest; 2019 Jan; 129(1):388-405. PubMed ID: 30398465
[TBL] [Abstract][Full Text] [Related]
2. Restriction of C1-inhibitor activity in hereditary angioedema by dominant-negative effects of disease-associated SERPING1 gene variants.
Ryø LB; Haslund D; Rovsing AB; Pihl R; Sanrattana W; de Maat S; Palarasah Y; Maas C; Thiel S; Mikkelsen JG
J Allergy Clin Immunol; 2023 Nov; 152(5):1218-1236.e9. PubMed ID: 37301409
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a dominant-negative effect of a missense mutation in the SERPING1 gene responsible for hereditary angioedema type I.
Yasuno S; Ansai O; Hayashi R; Nakamura S; Shimomura Y
J Dermatol; 2021 Aug; 48(8):1243-1249. PubMed ID: 33914953
[TBL] [Abstract][Full Text] [Related]
4. SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes.
Ponard D; Gaboriaud C; Charignon D; Ghannam A; Wagenaar-Bos IGA; Roem D; López-Lera A; López-Trascasa M; Tosi M; Drouet C
Hum Mutat; 2020 Jan; 41(1):38-57. PubMed ID: 31517426
[TBL] [Abstract][Full Text] [Related]
5. Novel homozygous variants in the SERPING1 gene in two Turkish families with hereditary angioedema of recessive inheritance.
Mete Gökmen N; Rodríguez-Alcalde C; Gülbahar O; Lopez-Trascasa M; Onay H; López-Lera A
Immunol Cell Biol; 2020 Sep; 98(8):693-699. PubMed ID: 32445210
[TBL] [Abstract][Full Text] [Related]
6. The hereditary angioedema syndromes.
Schmaier AH
J Clin Invest; 2019 Jan; 129(1):66-68. PubMed ID: 30530986
[TBL] [Abstract][Full Text] [Related]
7. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
Busse P; Kaplan A
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.
Veronez CL; Christiansen SC; Smith TD; Riedl MA; Zuraw BL
Allergy Asthma Proc; 2021 Nov; 42(6):506-514. PubMed ID: 34871158
[No Abstract] [Full Text] [Related]
9. Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization.
Christiansen SC; Zuraw BL
Immunol Allergy Clin North Am; 2024 Aug; 44(3):543-560. PubMed ID: 38937015
[TBL] [Abstract][Full Text] [Related]
10. sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor.
Larrauri B; Hester CG; Jiang H; Miletic VD; Malbran A; Bork K; Kaplan A; Frank M
Mol Immunol; 2020 Mar; 119():27-34. PubMed ID: 31955064
[TBL] [Abstract][Full Text] [Related]
11. Hereditary angioedema nationwide study in Slovenia reveals four novel mutations in SERPING1 gene.
Rijavec M; Korošec P; Šilar M; Zidarn M; Miljković J; Košnik M
PLoS One; 2013; 8(2):e56712. PubMed ID: 23437219
[TBL] [Abstract][Full Text] [Related]
12. Current update on cellular and molecular mechanisms of hereditary angioedema.
Walford HH; Zuraw BL
Ann Allergy Asthma Immunol; 2014 May; 112(5):413-8. PubMed ID: 24484972
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of hereditary angioedema.
Davis AE
Clin Immunol; 2005 Jan; 114(1):3-9. PubMed ID: 15596403
[TBL] [Abstract][Full Text] [Related]
14. A novel murine in vivo model for acute hereditary angioedema attacks.
Bupp S; Whittaker M; Lehtimaki M; Park J; Dement-Brown J; Zhou ZH; Kozlowski S
Sci Rep; 2021 Aug; 11(1):15924. PubMed ID: 34354123
[TBL] [Abstract][Full Text] [Related]
15. Transmission patterns of C1-INH deficiency hereditary angioedema favors a wild-type male offspring: Our experience at Chandigarh, India.
Machhua S; Kumar Jindal A; Basu S; Jangra I; Barman P; Tyagi R; Sil A; Tyagi R; Kaur A; Chawla S; Kumaran SM; Dogra S; Dhaliwal M; Sharma S; Rawat A; Singh S
Immunobiology; 2024 Mar; 229(2):152790. PubMed ID: 38340462
[TBL] [Abstract][Full Text] [Related]
16. C1-Inhibitor: Structure, Functional Diversity and Therapeutic Development.
Karnaukhova E
Curr Med Chem; 2022; 29(3):467-488. PubMed ID: 34348603
[TBL] [Abstract][Full Text] [Related]
17. Genetic Study of Hereditary Angioedema Type I and Type II (First Report from Iranian Patients: Describing Three New Mutations).
Nabilou S; Pak F; Alizadeh Z; Fazlollahi MR; Houshmand M; Ayazi M; Mohammadzadeh I; Bemanian MH; Fayezi A; Nabavi M; Saghafi S; Mohammadian S; Kokhaei P; Moin M; Pourpak Z
Immunol Invest; 2022 Jan; 51(1):170-181. PubMed ID: 32896191
[TBL] [Abstract][Full Text] [Related]
18. Hereditary angioedema in a Jordanian family with a novel missense mutation in the C1-inhibitor N-terminal domain.
Jaradat SA; Caccia S; Rawashdeh R; Melhem M; Al-Hawamdeh A; Carzaniga T; Haddad H
Mol Immunol; 2016 Mar; 71():123-130. PubMed ID: 26895475
[TBL] [Abstract][Full Text] [Related]
19. The future of therapeutic options for hereditary angioedema.
Smith TD; Riedl MA
Ann Allergy Asthma Immunol; 2024 Apr; ():. PubMed ID: 38679158
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of hereditary angioedema.
Zuraw BL; Christiansen SC
Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
